Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by Nohandledzepon Apr 16, 2014 12:02pm
296 Views
Post# 22458579

RE:RE:Updated Reports from Cormack and Wedbush

RE:RE:Updated Reports from Cormack and Wedbush
I see 3 options;

1) A full buyout in the $2-$3 range, assuming that there are competitive bids

2)A share consolidation ( that no current retail shareholders will like) a 30 mil financing and a US listing ...with Wedbush as the catalyst and driver.

3) a partner with a marketing and milestone arrangements to finance the balance of the trial and possible expansion of sites to shorten its length.

Common sense says that after the long delayed interim numbers, and a clear look at the finish line money will come knocking in one form or another.

I hope I am wrong, but In my opinion the SP is setting up for number 2. The SP looks intentionally range bound, for a huge placement to friendly hands, at the expense of the rest of us. With minimal effort money could be raised from $1.00 but it appears that shares will be given away in the 30 cent range.
Bullboard Posts